Neogene Therapeutics

📍 Amsterdam, Netherlands🗓 Founded 2018👥 134 employees💰 Last funded Sep 2020
Biotechnology Research🌐 neogene.com
Website LinkedIn
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Neogene Therapeutics?
Neogene Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Neogene Therapeutics last raise funding?
The most recent investment in Neogene Therapeutics recorded on gritt.io was in September 2020.
When was Neogene Therapeutics founded?
Neogene Therapeutics was founded in 2018.
What industry is Neogene Therapeutics in?
Neogene Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neogene Therapeutics based?
Neogene Therapeutics is headquartered in Amsterdam, Netherlands.